Chemokines signal the future in the treatment of SARS-CoV-2 infection
In a recent report1, researchers have described an ELISA (enzyme-linked immunosorbent assay) approach for the identification and quantification of antibodies that attach to a functional N-terminal loop area in human chemokines using plasma from heterogeneous cohort previously infected with SARS-CoV-2.
Download the article to find out more.View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.